Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Hajipur, Bihar, India.
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Kolkata, West Bengal, India.
Rapid Commun Mass Spectrom. 2024 Jun 15;38(11):e9747. doi: 10.1002/rcm.9747.
N-Nitroso dimethylamine (NDMA) is a mutagenic impurity detected in several ranitidine products. The amino functional group of ranitidine is a risk factor for classical nitrosation-induced NDMA formation in ranitidine drug products during storage conditions. The United States Food and Drug Administration (US FDA) recommended the use of antioxidants to control NDMA in drug products. Considering the need for sensitive analytics, a liquid chromatography/high-resolution mass spectrometry (LC-HRMS) method was developed and validated to detect NDMA in this pilot study to demonstrate the antioxidants as inhibitors of nitrosation reactions.
The method, utilizing an EC-C18 column and tuned to atmospheric pressure chemical ionization/selected ion monitoring (APCI/SIM) mode, separated NDMA (m/z: 75.0553; tR: 3.71 min) and ranitidine (m/z: 315.1485; tR: 8.61 min). APCI mode exhibited four times higher sensitivity to NDMA than electrospray ionization (ESI) mode. Classical nitrosation of the dimethyl amino group of ranitidine was studied with sodium nitrite in solid pellets. Antioxidants (alpha-tocopherol, ascorbic acid, and trolox) were evaluated as NDMA attenuators in ranitidine pellets under vulnerable storage conditions. The developed method quantified NDMA levels in samples, extracted with methanol through vortex shaking for 45 min.
The method achieved a limit of detection (LOD) and limit of quantitation (LOQ) of 0.01 and 0.05 ng/mL, respectively, with linearity within 1-5000 ng/mL (R: 0.9995). It demonstrated good intra-day and inter-day precision (% RSD [relative standard deviation]: <2) and accuracy (96.83%-101.72%). Nitrosation of ranitidine induced by nitrite was significant (p < 0.001; R = 0.9579) at various sodium nitrite levels. All antioxidants efficiently attenuated NDMA formation during ranitidine nitrosation. Ascorbic acid exhibited the highest NDMA attenuation (96.98%), followed by trolox (90.58%). This study recommends 1% ascorbic acid and trolox as potent NDMA attenuators in ranitidine drug products.
This study compared the effectiveness of antioxidants as NDMA attenuators in ranitidine under storage conditions susceptible to NDMA generation. The study concluded that ascorbic acid and trolox are potent inhibitors of NDMA formation and nitrosation attenuators in ranitidine drug products.
N-亚硝基二甲胺(NDMA)是在几种雷尼替丁产品中检测到的诱变杂质。雷尼替丁的氨基官能团是雷尼替丁药物在储存条件下经典亚硝化诱导 NDMA 形成的危险因素。美国食品和药物管理局(US FDA)建议使用抗氧化剂来控制药物产品中的 NDMA。考虑到需要进行敏感分析,开发并验证了一种液相色谱/高分辨率质谱(LC-HRMS)方法,以在本试点研究中检测 NDMA,证明抗氧化剂是亚硝化反应的抑制剂。
该方法利用 EC-C18 柱,调谐至大气压化学电离/选择离子监测(APCI/SIM)模式,分离 NDMA(m/z:75.0553;tR:3.71 min)和雷尼替丁(m/z:315.1485;tR:8.61 min)。APCI 模式对 NDMA 的灵敏度比电喷雾电离(ESI)模式高四倍。用亚硝酸钠在固体丸剂中研究雷尼替丁二甲氨基的经典亚硝化。在易产生 NDMA 的储存条件下,评估抗氧化剂(α-生育酚、抗坏血酸和 Trolox)作为雷尼替丁丸中的 NDMA 衰减剂。开发的方法通过涡旋摇动 45 分钟用甲醇提取样品,定量测定 NDMA 水平。
该方法的检测限(LOD)和定量限(LOQ)分别为 0.01 和 0.05 ng/mL,线性范围为 1-5000 ng/mL(R:0.9995)。它表现出良好的日内和日间精密度(%RSD[相对标准偏差]:<2)和准确性(96.83%-101.72%)。亚硝酸钠在不同水平下诱导雷尼替丁的亚硝化作用非常显著(p<0.001;R=0.9579)。所有抗氧化剂均能有效抑制雷尼替丁亚硝化过程中 NDMA 的形成。抗坏血酸表现出最高的 NDMA 衰减(96.98%),其次是 Trolox(90.58%)。本研究建议在雷尼替丁药物产品中使用 1%抗坏血酸和 Trolox 作为有效的 NDMA 衰减剂。
本研究比较了抗氧化剂在易产生 NDMA 的储存条件下作为雷尼替丁 NDMA 衰减剂的有效性。研究得出结论,抗坏血酸和 Trolox 是雷尼替丁药物产品中 NDMA 形成和亚硝化抑制剂的有效抑制剂。